Drugs / Gam-COVID-Vac (rAd26)
last change Sep 2021 re-read 2 minutes ago

Gam-COVID-Vac (rAd26)

Vaccine

Investigated by
Ministerio de Salud de Ciudad Autónoma de Buenos Aires

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05027672 Jul → Aug 2021 Ministerio de Salud de Ciudad Autónoma de Buenos Aires Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Gam-COVID-Vac (rAd26) ClinicalTrials.gov intervention name — accepted as the source's own label NCT05027672
Modality Vaccine “first component of the Sputnik V vaccine (rAd26)” NCT05027672